Our results reveal that there is correlation between CD40 mutant expression and the stages of gastric cancer as well as the prognosis, implying a possibility that the specific antibody of CD40 mutant may induce the apoptosis of gastric cancer cells, which means that CD40 mutant could be considered as a new target for tumor immunotherapy and immune intervention. This evidence concerns the gene CD40 and neoplasm.